Alfresa Holdings Corporation (2784) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Alfresa Holdings Corporation (2784:JPX), powered by AI.

Current Price
¥2,200
P/E Ratio
14.9
Market Cap
409.4B
Sector
Healthcare
What is the Alfresa Holdings Corporation stock price forecast?

Alfresa Holdings Corporation is currently trading at ¥2,200. View real-time AI analysis on Alpha Lenz.

What is Alfresa Holdings Corporation insider trading activity?

View the latest insider trading data for Alfresa Holdings Corporation on Alpha Lenz.

What is Alfresa Holdings Corporation's P/E ratio?

Alfresa Holdings Corporation's P/E ratio is 14.9.

Alfresa Holdings Corporation

JPX · 2784
¥2,200-5(-0.25%)Market closedJPX regular session 09:00–15:00 JST
Ask about Alfresa Holdings Corporation's future dividend policy...
Alpha Chat Insight

Alfresa Holdings Corporation trades at a P/E of 14.9 (undervalued) with modest ROE of 5.7%.

Ask for details

Company Overview

Alfresa Holdings Corporation is a prominent player in the Japanese healthcare and pharmaceutical distribution industry. Established in 2003 and headquartered in Tokyo, Alfresa Holdings is involved in the wholesale distribution of pharmaceuticals, diagnostic reagents, and medical devices. The company's primary function is to facilitate the reliable and efficient delivery of healthcare products from manufacturers to healthcare facilities, pharmacies, and consumers across Japan. Alfresa operates through a network of subsidiaries and associates, ensuring a wide-reaching and robust supply chain that supports the daily operations of the healthcare sector. Additionally, the company is actively engaged in promoting the development of healthcare solutions aimed at improving patient care and healthcare management. In the financial markets, Alfresa Holdings Corporation is recognized for its significant contributions to the healthcare supply chain, impacting sectors such as pharmaceuticals, biotechnology, and medical technology. This role underscores its importance in ensuring that essential medicines and medical supplies are readily available, thus supporting the health and wellbeing of communities throughout Japan.

CEOMr. Ryuji Arakawa
SectorHealthcare
IndustryMedical Distribution
Employees12,452

Company Statistics

FY 2025

Profile

¥409,424,152,462Market Cap
¥2,961,051,000,000Revenue
0.00Shares Out
12,452Employees

Margins

7.22%Gross
1.88%EBITDA
1.29%Operating
1.33%Pre-Tax
0.93%Net

Valuation

14.95P/E
0.85P/B
0.14EV/Sales
4.82EV/EBITDA
-28.26P/FCF

Growth (CAGR)

4.62%Rev 3Yr
1.87%Rev 5Yr
9.39%Op Inc 3Yr
-4.38%Op Inc 5Yr
-5.20%Net Inc 3Yr
-7.41%Net Inc 5Yr

Returns

1.90%ROA
5.70%ROE
2.75%ROIC

Financial Health

¥177,085,000,000Cash & Cash Equivalents
¥780,554,000,000Net Debt
198.58%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Alfresa Holdings Corporation (ticker: 2784) is a company listed on JPX in the Healthcare sector (Medical Distribution). It has approximately 12,452 employees. Market cap is $409.4B.

The current price is 2,200 with a P/E ratio of 14.95x and P/B of 0.85x.

ROE is 5.70% and operating margin is 1.29%. Annual revenue is $3.0T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Alfresa Holdings Corporation (2784) Stock Forecast 2026 ¥2,200 — Price, Financials & Analyst Targets | Alpha Lenz